Isaac Barchas
Directeur/Membre du Conseil chez IMMUNOME, INC.
Fortune : 2 M $ au 30/04/2024
Profil
Isaac Barchas is the founder of MorphImmune, Inc. He currently holds the position of Lead Independent Director at Immunome, Inc. He is also a Director at Pecan Street, Inc., Novosteo, Inc., Eradivir, Inc., Tetricus Labs, and Managing Director at Arsenal Bridge Venture II LLC and Rbp Catalyst Fund 1.
Previously, he served as President & Chief Executive Officer at Research Bridge Partners from 2017 to 2024.
He was also an Independent Director at Sustainable Opportunities Acquisition Corp.
from 2020 to 2021.
Additionally, he worked as a Director at Austin Technology Incubator from 2006 to 2016 and served as a Board member at The Austin Chamber of Commerce from 2007 to 2009.
Mr. Barchas completed his undergraduate degree at Stanford University in 1989 and obtained his graduate and doctorate degrees from The University of Chicago in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IMMUNOME, INC.
0,20% | 27/10/2023 | 121 680 ( 0,20% ) | 2 M $ | 30/04/2024 |
Postes actifs de Isaac Barchas
| Sociétés | Poste | Début |
|---|---|---|
| IMMUNOME, INC. | Directeur/Membre du Conseil | 02/10/2023 |
Pecan Street, Inc.
 Pecan Street, Inc. Miscellaneous Commercial ServicesCommercial Services Pecan Street, Inc. is a non-profit company that conducts research on water and energy. The company is based in Austin, TX. | Directeur/Membre du Conseil | - |
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Fondateur | - |
Eradivir, Inc.
 Eradivir, Inc. BiotechnologyHealth Technology Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low. | Directeur/Membre du Conseil | - |
Tetricus Labs
 Tetricus Labs Packaged SoftwareTechnology Services Tetricus Labs is a company that develops a platform for patients to manage their own care. The company is based in New Haven, NY. The company was founded in 2022 by Sean McCurdy, Phil Corlett, Lindsay Dow. Lindsay Dow has been the CEO since 2022. | Directeur/Membre du Conseil | - |
Novosteo, Inc.
 Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Directeur/Membre du Conseil | - |
| Arsenal Bridge Venture Ii LLC | Corporate Officer/Principal | - |
Anciens postes connus de Isaac Barchas
| Sociétés | Poste | Fin |
|---|---|---|
Research Bridge Partners /Venture Capital/
 Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Directeur Général | 01/01/2024 |
| SUSE OPPO | Directeur/Membre du Conseil | 01/09/2021 |
| ░░░░░░ ░░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░ ░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Isaac Barchas
| Stanford University | Undergraduate Degree |
| The University of Chicago | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| IMMUNOME, INC. | Health Technology |
| Entreprise privées | 10 |
|---|---|
The Austin Chamber of Commerce
 The Austin Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Austin Chamber of Commerce is an organization that helps people in the region achieve greater prosperity by working with businesses looking to create or expand their presence in the Austin region and help them create more jobs. The non-profit company is based in Austin, TX. The company has helped bring more than 400,000 jobs to the region since 2004 and take on the biggest challenges so businesses can focus on growing. Laura Huffman has been the CEO of the company since 2020. | Commercial Services |
Austin Technology Incubator
 Austin Technology Incubator Miscellaneous Commercial ServicesCommercial Services Austin Technology Incubator is a deep tech incubator affiliated with the University of Texas at Austin. The non-profit company is based in Austin, TX. The company's mission is to empower university and community entrepreneurs through a customized approach to effectively commercialize their breakthrough innovations and compete in the marketplace. The company is committed to supporting deep tech solutions that will become the future for today's challenges. It was founded in 1989 and is the longest active technology incubator in Austin. The company was founded by Tab Ebrahim, Robert Norman Neville, Bart Bohn. | Commercial Services |
Pecan Street, Inc.
Pecan Street, Inc. Miscellaneous Commercial ServicesCommercial Services Pecan Street, Inc. is a non-profit company that conducts research on water and energy. The company is based in Austin, TX. | Commercial Services |
Research Bridge Partners /Venture Capital/
Research Bridge Partners /Venture Capital/ Investment ManagersFinance Research Bridge Partners (Research Bridge Partners) is a venture capital firm founded in 2016 by Reid Hoffman. The firm is headquartered in Austin, Texas. | Finance |
Novosteo, Inc.
Novosteo, Inc. Pharmaceuticals: MajorHealth Technology Novosteo, Inc. develops drug to reduce complications from a broken bone. The company was founded by Stewart A. Low and Philips S. Low in 2017 and is headquartered in West Lafayette, IN. | Health Technology |
Sustainable Opportunities Acquisition Corp.
 Sustainable Opportunities Acquisition Corp. Financial ConglomeratesFinance Sustainable Opportunities Acquisition Corp. is a blank check company with no operating history and no revenues. The company was founded in 2019 is headquartered in Dallas, TX. | Finance |
Eradivir, Inc.
Eradivir, Inc. BiotechnologyHealth Technology Eradivir, Inc. is a company that builds targeted therapeutics for infectious diseases. Eradivir spun out of a multi-year research and technology development program in Philip Low's lab in 2020. The company is based in West Lafayette, IN. The company has developed a universal platform against influenza and is now applying these technologies to SARS-CoV-2, the virus that causes COVID-19. The company was founded by Philip S. Low and Martin R. Low. | Health Technology |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
| Arsenal Bridge Venture Ii LLC | |
Tetricus Labs
Tetricus Labs Packaged SoftwareTechnology Services Tetricus Labs is a company that develops a platform for patients to manage their own care. The company is based in New Haven, NY. The company was founded in 2022 by Sean McCurdy, Phil Corlett, Lindsay Dow. Lindsay Dow has been the CEO since 2022. | Technology Services |
